• 1. Fe3O4/PEG-SO3H as a heterogeneous and magnetically-recyclable nanocatalyst for the oxidation of sulfides to sulfones or sulfoxides
  Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761
• 2. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks
  BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller
• 3. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477
• 4. Estimation of hydrogen sulfide from crude petroleum: a unique invention using a simple chemosensor?
  Shampa Kundu,Prithidipa Sahoo New J. Chem., 2019,43, 12369-12374
• 5. Enantiomeric helical TiO2 nanofibers modulate different peptide assemblies and subsequent cellular behaviors?
  Xu Jie,Deng Xu,Weili Wei RSC Adv., 2019,9, 29149-29153

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzodioxoles Benzodioxoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzodioxoles

Introduction to 1-(2H-1,3-benzodioxol-5-yl)-2-bromoethan-1-one (CAS No. 40288-65-1)

1-(2H-1,3-benzodioxol-5-yl)-2-bromoethan-1-one, identified by its Chemical Abstracts Service (CAS) number 40288-65-1, is a significant compound in the realm of pharmaceutical chemistry and medicinal research. This heterocyclic ketone features a unique structural framework that has garnered attention for its potential applications in drug discovery and synthetic organic chemistry. The compound’s molecular structure incorporates a benzodioxole moiety, which is known for its biological activity, alongside a brominated ethyl group that enhances its reactivity and utility in various chemical transformations.

The benzodioxole scaffold, also referred to as an oxygenated dibenzo-p-dioxin derivative, is a key pharmacophore in many bioactive molecules. Its presence in 1-(2H-1,3-benzodioxol-5-yl)-2-bromoethan-1-one suggests potential interactions with biological targets, making it a valuable candidate for further exploration in medicinal chemistry. The bromine substituent at the second carbon of the ethyl chain introduces electrophilic characteristics, facilitating nucleophilic substitution reactions that are pivotal in the synthesis of more complex molecules.

In recent years, there has been growing interest in developing novel compounds with benzodioxole derivatives due to their demonstrated pharmacological properties. These include anti-inflammatory, antimicrobial, and even anticancer effects, depending on the substitution pattern and overall molecular configuration. The specific arrangement of atoms in 1-(2H-1,3-benzodioxol-5-yl)-2-bromoethan-1-one positions it as a versatile intermediate for constructing more elaborate pharmacological agents.

From a synthetic perspective, 1-(2H-1,3-benzodioxol-5-yl)-2-bromoethan-1-one serves as a building block for the preparation of more intricate heterocyclic compounds. The bromine atom allows for further functionalization via cross-coupling reactions such as Suzuki or Buchwald-Hartwig couplings, enabling the introduction of aryl or alkyl groups at various positions. This flexibility is particularly useful in generating libraries of compounds for high-throughput screening (HTS) to identify lead candidates for drug development.

Recent advancements in computational chemistry have also highlighted the importance of molecular descriptors like polarity, hydrogen bonding potential, and lipophilicity in determining the bioactivity of small molecules. The electronic distribution and steric environment around the benzodioxole ring and the brominated ethyl group in 1-(2H-1,3-benzodioxol-5-yl)-2-bromoethan-1-one make it an interesting subject for computational modeling studies aimed at predicting its interaction with biological targets.

The compound’s relevance extends to materials science as well. Functionalized benzodioxole derivatives have been explored for their potential applications in organic electronics and photovoltaic devices due to their ability to form stable π-conjugated systems. While 1-(2H-1,3-benzodioxol-5-yl)-2-bromoethan-1-one may not be directly used in these applications yet, its structural components could inspire novel materials with enhanced performance characteristics.

In academic research circles, 1-(2H-1,3-benzodioxol-5-yl)-2-bromoethan-1-one has been employed in studies focusing on the development of new synthetic methodologies. For instance, researchers have utilized this compound to investigate catalytic systems that improve the efficiency of bromination reactions or to develop asymmetric synthesis strategies that preserve stereochemical integrity during functionalization.

The pharmaceutical industry has also shown interest in exploring derivatives of 1-(2H-1,3-benzodioxol-5-yl)-2-bromoethan-1-one for their potential therapeutic benefits. By modifying the substituents on the benzodioxole ring or the brominated ethyl chain, chemists aim to optimize pharmacokinetic properties such as solubility, bioavailability, and metabolic stability. Such modifications are critical steps toward translating promising candidates into viable drug candidates.

As our understanding of chemical biology evolves, so does the role of intermediates like CAS No. 40288-65-1. The ability to precisely control molecular structure allows researchers to fine-tune interactions with biological pathways at an unprecedented level. This precision is essential for developing treatments that are not only effective but also minimally invasive to normal physiological processes.

The future prospects for 1-(2H-1,3-benzodioxol-5-ylyl)-2-bromoethanone (CAS No. 40288651) are bright given its versatility and utility across multiple scientific disciplines. Continued research will likely uncover new synthetic applications and expand its role in pharmaceutical development. As synthetic chemists refine their techniques and computational tools become more sophisticated, compounds like this will remain at the forefront of innovation.

• 5000-65-7(2-Bromo-3'-methoxyacetophenone)
• 3162-29-6(1-(2H-1,3-benzodioxol-5-yl)ethan-1-one)
• 83963-15-9(1-Propanone,1-(1,3-benzodioxol-5-yl)-2-bromo-)
• 783321-45-9(Ethanone, 1-(1,3-benzodioxol-5-yl)-2,2-dibromo-)
• 72337-31-6(Ethanone, 2-bromo-1-(6,7-dimethoxy-2-naphthalenyl)-)
• 1835-02-5(2-bromo-1-(3,4-dimethoxyphenyl)ethan-1-one)
• 88950-07-6(Ethanone, 1,1'-[methylenebis(oxy-4,1-phenylene)]bis[2-bromo-)
• 51149-28-1(a-Bromoacetosyringone)
• 52190-28-0(1-(Benzo[d][1,3]dioxol-5-yl)-2-bromopropan-1-one)
• 69638-06-8(2-Bromo-1-(4-hydroxy-3-methoxyphenyl)ethanone)